New drug shows promise for chronic blood disorder in small trial
NCT ID NCT04669600
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 36 times
Summary
This study tested an experimental drug called BIVV020 in 12 adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The goal was to see if the drug could safely raise and maintain platelet counts without needing rescue treatments. Results help guide future research on managing this chronic condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA (ITP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number :2030002
Ostrava - Poruba, 70852, Czechia
-
Investigational Site Number :2760001
Essen, 45147, Germany
-
Investigational Site Number :5280001
Leiden, 2333 ZA, Netherlands
-
Investigational Site Number :7240001
Palma de Mallorca, 07120, Spain
-
Investigational Site Number :7240002
A Coruña, A Coruña [La Coruña], 15006, Spain
-
Investigational Site Number :7240003
Seville, 41013, Spain
-
Investigational Site Number :8260002
London, London, City of, W12 0HS, United Kingdom
-
Investigational Site Number :8400001
Washington D.C., District of Columbia, 20007, United States
-
Investigational Site Number :8400002
Tamarac, Florida, 33321, United States
Conditions
Explore the condition pages connected to this study.